Hong Kong Entertainment Stock News

Shanghai Haohai Biological Technology heads into this earnings season with a stock that has slipped about 18% over the past three months, yet trades on a P/E of 20.7 that still sits below the broader Hong Kong biotech industry. The market has been fixated on dividend yield and headline earnings volatility. The key issue in this Q2 release is the profit squeeze behind those headlines. Trailing net margin is 6.5% compared with 15.4% a year earlier, and the period includes a large one-off loss...

CITIC Resources Holdings went into its H1 2026 earnings with the stock at HK$0.51, up over the past month but still weaker over the last quarter. The headline was not revenue growth; the story was profit. Basic earnings per share for the half came in at HK$0.0363, against modest earnings in H2 2025, with net income at HK$285.6m on HK$5.1b of revenue. Short term traders saw a low priced stock move. Longer term investors now have to weigh that profit rebound against a higher 13.2x trailing P/E...

Shanghai Henlius Biotech went into its H1 2026 earnings with a rich 38.7x P/E and a stock that had climbed 19.1% over the past month, so expectations were already elevated. The headline this time is about profitability pressure. Net profit margin over the last year sat at 12.4%, below the prior 14.3%, while trailing earnings growth of 0.8% lagged far behind the earlier five year pace. For a biotech priced above the sector average, that margin squeeze is likely to frame every conversation...

The market had China Leon Inspection Holding parked flat at HK$1.72 coming into the fresh H1 2026 numbers, with the stock going nowhere over the past week and barely moved over the past month. The calm price action sits awkwardly against an earnings story anchored on margin pressure. Net profit margin over the last year sat at 2.9% compared with 6.5% in the prior year, while the trailing P/E near 26x still prices the stock in line with peers. The key question for you is whether that valuation...

East Buy Holding stock closed at HK$20.22 on the day of its full year 2026 results, capping a rough three months with a decline of about 11%. That short term slide sits awkwardly against a very sharp earnings rebound, with trailing net margin at 9.5% compared with almost flat profitability a year ago and a trailing P/E of 33.6x that reflects high expectations. The real focus now is not today’s share price move; it is whether this earnings surge and improved margins can justify a valuation...

Investors walked into TUHU Car’s H1 2026 earnings with a stock that has drifted in the short term and fallen about 13.2% over the past 90 days, yet still carries a rich 27.5x P/E compared with cheaper Hong Kong commercial services peers. The headline from this report is margin pressure. Trailing net profit margin now sits at 1.7%, about half the 3.3% level from a year earlier, even with revenue for the half year at ¥8,777.8m. That squeeze is the pressure point the share price will have to...

Smart Globe Holdings entered this earnings release with a flat 7 day share price and a 90 day slide, yet the latest numbers point to a very different story. The stock closed at HK$1.50 today while the business reported sharply higher half year revenue of HK$190.734 million and Basic EPS of HK$0.0137. The real flashpoint is valuation. A P/E of 113.5x and a share price sitting above an estimated cash flow value of HK$1.08 mean today’s muted price reaction looks more like nerves about what is...

China Coal Energy walked into this earnings day with a stock that has barely moved over the past month but still trades on a single digit P/E and well below many valuation estimates. The headline from Q2 is a revenue haul of C¥38,947.4m that sits alongside C¥4,347.5m in net income, keeping profitability in focus for a sector where margins can swing hard with coal pricing. The market reaction will hinge on whether investors treat this as a confirmation of resilient earnings power or stay...

Jinxin Fertility Group stock closed at HK$2.23 on the day of its H1 2026 results, capping a flat month but a slightly positive week. The market look is calm. The earnings story is not. The headline is a clean return to profit, with basic earnings per share back in positive territory and net income from ongoing operations in the black for the trailing year. The key question for you is whether that profitability shift is being treated as routine, when it directly contrasts with the heavy loss...

The market has largely shrugged at Prosperous Industrial (Holdings), with the share price flat over the past week and weaker over three months, even as the latest half year numbers show a different story. H1 2026 revenue reached US$131.9m and net income came in at US$11.7m, while the stock trades on a trailing P/E of about 5x. The headline this time is the pressure on profitability, with the trailing net margin at 9.1% compared with 10.5% a year ago. That margin squeeze is what investors now...

Traders barely moved on Lung Kee Group Holdings today, with the stock flat over the past week and month even as fresh half year numbers hit the tape. That calm surface hides a harsher reality for longer term holders. The mould base manufacturer is still loss making, with first half 2026 earnings per share in a small loss and trailing 12 month income also in the red. The bigger story now sits on the balance between those persistent losses and a dividend yield of 16.55% that current earnings...

Home Control International stock came into this earnings print treading water, roughly flat over the past week and down over the past quarter, even with the shares trading well below a discounted cash flow estimate. The new H1 2026 numbers drop straight into that valuation debate. Revenue of US$47.5m and net income of US$2.1m keep the business profitable, but the key tension for you is simple: the market is pricing a high trailing P/E against a stock that screens cheap on a discounted cash...

China Nonferrous Mining stock closed at HK$15.33 after the market had a full day to chew over the H1 2026 numbers. Short term traders saw a copper producer that has already climbed about 7.9% over the past week and roughly 8.8% over three months. The real story sits in profit power. Net income from ongoing operations reached US$834.7m on a trailing twelve month basis, and net profit margins are described as stronger than a year ago. For anyone thinking beyond the next few sessions, this...

Dongyue Group (SEHK:189) drew fresh attention after reporting higher half year sales of CNY 8,059.97 million and net income of CNY 1,026.98 million, with earnings per share of CNY 0.60. See our latest analysis for Dongyue Group. The earnings release has gone hand in hand with stronger share price momentum for Dongyue Group, with a 1 day share price return of 9.65% and year to date share price return of 24.49%. In addition, the 3 year total shareholder return of 103.51% highlights how the...

China Petroleum & Chemical Corporation recently held a board meeting on 21 August 2026 to approve its interim results for the six months ended 30 June 2026, while Chinese refiners collectively secured about 24 million barrels of Saudi crude through a rare tender and long-term contracts. The combination of interim results approval and sizeable Saudi crude purchases highlights how Sinopec is managing both corporate governance milestones and physical supply security in a tight global energy...

AAC Technologies Holdings (SEHK:2018) drew fresh attention after reporting its half year 2026 results. Sales reached CNY 14,506.45 million and net income was CNY 901.3 million, both higher than the prior period. See our latest analysis for AAC Technologies Holdings. The latest half year results and earnings call appear to have shifted attention back to AAC Technologies Holdings, with the stock closing at HK$40.1 after a 1 day share price return of 2.51%. Even so, the 1 year total shareholder...

Ping An Healthcare and Technology (SEHK:1833) reported half year 2026 earnings with sales of CNY 2,483.83 million and net income of CNY 219.33 million, alongside basic and diluted EPS of CNY 0.10. See our latest analysis for Ping An Healthcare and Technology. The earnings release on 18 August has come after a weak stretch for Ping An Healthcare and Technology, with the share price at HK$6.735 and the year-to-date share price return down 53.81%, while the 3-year total shareholder return is...

China Tower (SEHK:788) recently reported half year 2026 results and announced an interim cash dividend, giving investors fresh information on both earnings and shareholder payouts ahead of key September and October dates. See our latest analysis for China Tower. Despite the interim dividend and stronger half year earnings, China Tower's share price return has been mixed, with the stock up 1.63% over the last day but down 19.95% year to date. The 3 year total shareholder return of 36.74%...

After a long run where a handful of U.S. mega caps have dominated headlines, rising concentration risk, choppy sector leadership and fresh geopolitical worries are pushing more investors to rethink where their income comes from. That shift is creating a window for real asset stocks that offer clearer cash flow stories. This article walks through three stocks from our global real asset income screener that appear closely tied to the latest news drivers. The three stocks highlighted below are...

How East Buy Holding’s latest earnings are shaping investor focus East Buy Holding (SEHK:1797) has drawn fresh attention after releasing full year results to May 31, 2026, reporting sales of CNY 5,701.01 million and net income of CNY 543.55 million. See our latest analysis for East Buy Holding. Alongside these earnings, East Buy Holding’s share price has fallen 12.62% over the past month and 11.24% over the past quarter, even though the year to date share price return is up 11.77% and the 5...

CSC Financial Co., Ltd. reported past half-year results for the period ended June 30, 2026, with revenue of CNY 16,228.81 million and net income of CNY 7,639.13 million, both higher than the same period a year earlier. Basic and diluted earnings per share from continuing operations rose to CNY 0.92 from CNY 0.52, highlighting stronger profitability on a per-share basis. With this sharp improvement in per-share earnings, we will now examine how the results shape CSC Financial’s broader...

Impro Precision Industries (SEHK:1286) drew investor attention after reporting half year 2026 sales of HK$3,018.05 million and net income of HK$421.04 million, alongside an interim dividend of HK$0.08 per share. See our latest analysis for Impro Precision Industries. The latest half year results and interim dividend seem to be feeding into strong momentum in Impro Precision Industries, with the share price at HK$9.0 and a year to date share price return of 77.87%. The 1 year total shareholder...

It's common for many investors, especially those who are inexperienced, to buy shares in companies with a good story...

SINOPEC Engineering (Group) (SEHK:2386) has drawn fresh attention after announcing a new share repurchase plan of up to HK$150 million, alongside interim results showing higher sales but lower net income for the first half of 2026. See our latest analysis for SINOPEC Engineering (Group). Set against the new HK$150 million repurchase plan and a lower interim dividend, SINOPEC Engineering (Group)'s recent 1 day share price return of 2.48% contrasts with a year to date share price decline of...